Christoph Thomssen
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 136
- Protease and Inhibitor Mechanisms 27
- Cancer Genomics and Diagnostics 14
- Oncology top 0.2%
- Cancer Treatment and Pharmacology 83
- HER2/EGFR in Cancer Research 66
- Global Cancer Incidence and Screening 14
- Immunology and Allergy top 1%
-
- Breast Lesions and Carcinomas 35
- Hematology top 2%
-
- Advanced Breast Cancer Therapies 62
- Co-authors
- Nadia HarbeckManfred SchmittF. JänickeMichael GnantMichael UntchH. GraeffRudolf WankGϋnter von Minckwitz
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Christoph Thomssen
265 papers receiving 8.3k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 4.5k
- Oncology 4.9k
- Immunology and Allergy 467
- Pathology and Forensic Medicine 944
- Hematology 526
Countries citing papers authored by Christoph Thomssen
This map shows the geographic impact of Christoph Thomssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Thomssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Thomssen more than expected).
Fields of papers citing papers by Christoph Thomssen
This network shows the impact of papers produced by Christoph Thomssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Thomssen. The network helps show where Christoph Thomssen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christoph Thomssen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 26 | |
| 7 | 2019 | 34 | |
| 8 | 2014 | 35 | |
| 9 | 2012 | 44 | |
| 10 | 2010 | 126 | |
| 11 | 2010 | 141 | |
| 12 | 2010 | 50 | |
| 13 | 2010 | 220 | |
| 14 | 2010 | 55 | |
| 15 | 2007 | 27 | |
| 16 | 2007 | 93 | |
| 17 | 2006 | 55 | |
| 18 | Anthracycline and trastuzumab in breast cancer treatment. | 2004 | 6 |
| 19 | 2003 | 25 | |
| 20 | 1999 | 0 |
About Christoph Thomssen
Christoph Thomssen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 281 papers that have together received 8.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (136 papers), Cancer Treatment and Pharmacology (83 papers), HER2/EGFR in Cancer Research (66 papers), Advanced Breast Cancer Therapies (62 papers), Breast Lesions and Carcinomas (35 papers), Protease and Inhibitor Mechanisms (27 papers), Cancer Genomics and Diagnostics (14 papers) and Global Cancer Incidence and Screening (14 papers). The work is most often cited by research in Cancer Research (4.5k citations), Oncology (4.9k citations) and Immunology and Allergy (467 citations). Christoph Thomssen has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Nadia Harbeck, Manfred Schmitt, F. Jänicke, Michael Gnant, Michael Untch, H. Graeff, Rudolf Wank, Gϋnter von Minckwitz, Sibylle Loibl and Heinz Höfler. Their work appears in journals such as Breast Care, Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.